Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Patented drugs revenue in prescribed drug market in India 2008-2015

Revenue of patented drugs in prescribed drug market in India from 2008 to 2015 (in billion U.S. dollars)

by Sanika Diwanji, last edited Sep 23, 2019
Patented drugs revenue in prescribed drug market in India 2008-2015 This statistic displays the revenue generated by patented drugs in the prescribed drug market in India from 2008 to 2015. In 2015, patented drugs generated some 2.7 billion U.S. dollars in revenue, up from about 2.2 billion U.S. dollars in 2014.
Show more

Revenue of patented drugs in prescribed drug market in India from 2008 to 2015 (in billion U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical industry in India"
  • Key figures
The most important statistics
  • Finances and trade
  • Key players
  • Future outlook
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.